益肾复原方治疗肾精亏虚型老年性骨质疏松症的疗效评价
本文选题:益肾复原方 + 骨质疏松症 ; 参考:《浙江中医药大学》2016年硕士论文
【摘要】:目的通过董飞侠主任中医师治疗老年性骨质疏松症的经验方益肾复原方的临床研究,评价其临床疗效,为中药复方的临床应用奠定理论基础,丰富中医临床抗骨质疏松症的治疗方案。方法将60例临床符合纳入标准的老年性骨质疏松症且中医辨证为肾精亏虚证患者,随机分为治疗组30例,对照组30例。对照组给予钙尔奇D片、罗盖全胶丸、阿仑膦酸钠治疗。治疗组在对照组的基础上给予益肾复原方煎剂,每日1剂,每日2次,每次服用200ml。3个月为1个疗程,2个疗程后判断临床疗效,并观察记录其药物不良反应,于疗程结束后,复查实验室指标,并评价疗效。结果治疗组总体有效率为90%,对照组总体有效率为70%,经统计学分析差异有统计学意义(P0.05)。治疗前治疗组与对照组各中医证候评分比较无明显差异(P0.05)。治疗组与对照组在经过治疗后,治疗组在腰膝酸软、耳鸣耳聋、性欲减淡、发脱齿松、两足萎软、舌淡、脉弱等中医证候改善方面均优于对照组,在统计学上有显著差异(P0.05)。对于试验前、后血清Ca、P、ALP浓度变化情况,两组治疗前、后血清P、ALP的浓度无明显改变,差异无显著性意义(P0.05);两组治疗前、后血清Ca的浓度明显改变,差异有显著性意义(P0.05),治疗后组间比较,治疗组较对照组更能提高患者Ca浓度(P=0.3720.05);试验前、后血清PINP、β-CTx浓度变化情况,两组治疗前、后血清PINP、β-CTx的浓度明显改变,差异有显著性意义(P0.05);治疗后组间比较,治疗组较对照组更能提高患者PINP浓度,降低β-CTx的浓度(P0.05)。对于股骨颈(Neck)、股骨粗隆(Troch)和腰椎(L1-L4)骨密度检测比较情况,治疗组中治疗前后组内比较,P0.05,存显著性差异。对照组中治疗前后组内比较,P0.05,有显著性差异。两组治疗后组间比较,P0.05,有显著性差异。结论益肾复原方治疗老年性骨质疏松症具有较好的疗效,能显著改善患者的临床症状,试验组和对照组都可以改善患者骨密度值,提高血清PINP,降低血清β-CTX,加用益肾复原方,改善效果更明显,该复方能安全有效治疗老年性骨质疏松症。
[Abstract]:Objective to evaluate the clinical effect of Fang Yishen Restoration recipe through the experience of Director Dong Feixia in the treatment of senile osteoporosis, so as to lay a theoretical foundation for the clinical application of traditional Chinese medicine. Enrich the Chinese medicine clinical anti-osteoporosis treatment plan. Methods 60 cases of senile osteoporosis with syndrome differentiation of deficiency of kidney essence were randomly divided into treatment group (n = 30) and control group (n = 30). The control group was treated with calcium D tablet, Luogai total rubber pill and alendronate sodium. On the basis of the control group, the treatment group was given Yishen Restoration decoction once a day, twice a day, each time taking 200ml.3 for a course of treatment. After two courses of treatment, the clinical efficacy was evaluated, and the adverse drug reactions were observed and recorded. To review the laboratory indexes and evaluate the efficacy. Results the total effective rate was 90 in the treatment group and 70 in the control group. There was no significant difference in the scores of TCM syndromes between the treatment group and the control group before treatment (P 0.05). After treatment, the treatment group and the control group were superior to the control group in improving the TCM syndromes, such as weak waist and knee, tinnitus and deafness, decreased libido, loose hair, weak feet, weak tongue, weak pulse and so on. There was significant difference in statistics between the treatment group and the control group (P 0.05). Before and after the treatment, the changes of serum calcium concentration in the two groups were not obvious, but there was no significant difference between the two groups before and after the treatment, and the changes of the serum Ca levels before and after treatment in the two groups were not significant, but there was no significant difference between the two groups before and after the treatment. The difference was significant (P 0.05). Compared with the control group, the serum PINP and 尾 -CTx concentrations in the treatment group were significantly higher than those in the control group, and the changes of serum PINP and 尾 -CTx levels before and after the treatment were significantly different between the two groups before and after treatment. After treatment, the concentration of PINP in the treatment group was higher than that in the control group, and the concentration of 尾 -CTX was lower than that in the control group. The bone mineral density (BMD) of Neckus femoris trochanter and L1-L4 in the treatment group was significantly higher than that in the control group before and after treatment (P 0.05). In the control group, there was a significant difference between the two groups before and after treatment (P 0.05). There was significant difference between the two groups after treatment (P 0.05). Conclusion Yishenghuangfang has good curative effect on senile osteoporosis, and can improve the clinical symptoms of the patients. Both the experimental group and the control group can improve the bone mineral density, increase serum PINP, decrease serum 尾 -CTX, and add Yishen Restoration recipe. The improvement effect is more obvious, this compound can treat senile osteoporosis safely and effectively.
【学位授予单位】:浙江中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259
【相似文献】
相关期刊论文 前10条
1 陈齐鸣,龙爱华,卜平,孙振华;益肾蠲痹法治疗膝关节骨性关节炎临床及实验研究[J];实用临床医药杂志;2003年06期
2 张霞;益肾强筋汤治疗膝关节骨性关节炎42例小结[J];湖南中医药导报;2004年02期
3 孙继铭,薄庆,刘振寅;固本益肾膏治疗非微生物性尿道综合征[J];四川中医;1998年05期
4 王运泽,王建萍,李秀珍,郁彬;益肾补骨片治疗老年性骨质疏松症临床研究[J];山东中医杂志;2000年10期
5 孙金瑞;;益肾灵散治疗糖尿病神经源性膀胱163例[J];中国民间疗法;2009年09期
6 孙伟,高坤,周栋;益肾清利活血综合治疗局灶节段性肾小球硬化22例分析[J];中国中西医结合肾病杂志;2005年01期
7 郑昱村;赖坤女;刘云;王永华;;莲子益肾摄精汤治疗早泄50例观察[J];实用中医药杂志;2010年02期
8 张晓梅;尹婷;杨效华;吴海斌;姚金芳;;理肺益肾方对Ⅲ级慢阻肺患者肺功能变化的影响[J];中国实验方剂学杂志;2013年02期
9 张雨华;滋肝益肾膏的应用体会[J];南京中医药大学学报;1997年01期
10 曾再新;;养心益肾话莲肴[J];药膳食疗;2005年12期
相关会议论文 前10条
1 谢春光;;益肾糖泰防治糖尿病肾病的实验研究[A];糖尿病(消渴病)中医诊治荟萃——全国第五次中医糖尿病学术大会论文集[C];1999年
2 柳文晶;魏连波;龙海波;周伟东;;益肾清毒颗粒对慢性肾脏病(3、4期)晚期糖基化终产物和晚期氧化蛋白产物的影响[A];第10届全国中西医结合肾脏病学术会议论文汇编[C];2009年
3 王世晶;;益肾通窍法治疗前列腺增生20例[A];中国中西医结合学会泌尿外科专业委员会第三届全国学术会议论文汇编[C];2001年
4 王燕;周翠英;孙素平;;益肾祛瘀方治疗膝骨性关节炎的临床及实验研究[A];第十一届全国中医风湿病学术研讨会专辑[C];2006年
5 郭宝荣;杨文军;李英杰;;益肾壮骨合剂治疗老年糖尿病合并骨质疏松症36例的临床研究[A];第八次全国中医糖尿病学术大会论文汇编[C];2005年
6 李克明;陈玉武;李平;;柴黄益肾颗粒中活性物质分析[A];第八次全国中医药传承创新与发展学术研讨会论文集[C];2009年
7 陈双华;蒋成燕;陈登科;曹建林;;益肾解毒方治疗肾性贫血的疗效分析[A];第七届全国中西医结合肾脏病会议论文汇编[C];2003年
8 柳文晶;魏连波;龙海波;周伟东;;益肾清毒颗粒治疗慢性肾脏病(3、4期)-脾肾阳虚瘀浊互结证的有效性和安全性研究[A];第10届全国中西医结合肾脏病学术会议论文汇编[C];2009年
9 李克明;陈玉武;李平;;柴黄益肾颗粒中活性物质分析[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年
10 张晓娟;梁宏正;吴社泉;;益肾补血散治疗肾性贫血临床观察[A];第10届全国中西医结合肾脏病学术会议论文汇编[C];2009年
相关重要报纸文章 前10条
1 江苏南通良春风湿病医院 朱婉华;益肾蠲痹法治疗风湿难症[N];中国中医药报;2013年
2 问苑;呼吸益肾助回春[N];医药养生保健报;2007年
3 中华中医药学会风湿病分会副主任委员 朱婉华;益肾蠲痹 延缓强脊进展[N];健康报;2012年
4 江苏南通良春风湿病医院 朱婉华;益肾蠲痹,,治风湿修骨损[N];中国中医药报;2013年
5 记者 刘道安;益肾软坚法治疗崩漏效果好[N];健康报;2000年
6 江苏省中医院肾病科 孙伟;益肾清利活血 治慢性肾脏病心法[N];中国中医药报;2011年
7 徐传宏;强肾健脾常食莲[N];中国医药报;2000年
8 甘肃省泾川县卫生局 杨福盛;益肾保健良药枸杞子[N];中国中医药报;2011年
9 河南中医学院 教授 段振离;益肾又抗癌的覆盆子[N];家庭医生报;2004年
10 衣晓峰 靳万庆;调阴阳 益肾损 固肾气[N];中国中医药报;2006年
相关博士学位论文 前4条
1 殷燕云;基于对成纤维细胞调控探讨益肾化瘀法治疗盆腔炎性疾病后遗症机制[D];南京中医药大学;2014年
2 潘恩山;益肾通胶囊与增生前列腺细胞凋亡的相关性研究[D];广州中医药大学;2008年
3
本文编号:1861673
本文链接:https://www.wllwen.com/zhongyixuelunwen/1861673.html